How to cite this article
Bhowmick R, Gulla KM. Pediatric Acute Respiratory Distress Syndrome in COVID-19 Pandemic: Is it the Puzzle of the Century? Indian J Crit Care Med 2022;26(3):264–265.
Keywords: Acute respiratory distress syndrome, Children, COVID-19 acute respiratory distress syndrome
The world is currently facing one of the century's greatest challenges due to the pandemic caused by the novel coronavirus disease-2019 (COVID-19). Since inception, illness due to this virus varied globally in its severity. Initially, the virus caused diseases mainly in adult populations. However, children affected presented with milder clinical presentations.1 A recent retrospective study on 12,306 pediatric COVID-19 patients, hospitalization frequency was found as 5.3%, with 17.6% required critical care services and 4.1% of patients required mechanical ventilation support.2 Compared to the adult population, the mortality was significantly low in children requiring mechanical ventilation due to COVID-19.3 The differential expression of ACE2 receptors on alveolar epithelial cells compared to adults, competition with other common respiratory viruses, and differential T-cell expressions helping the immunity are some hypotheses behind the lesser severity of pediatric COVID-19 pneumonia.4,5 Multisystem inflammatory syndrome associated with COVID-19 (MIS-C) in children was another spectrum of this illness noted since April 2020, reported from various countries. Most patients with this syndrome had fever but gastrointestinal manifestations, like diarrhea, hematological, cardio-respiratory symptoms, and neurological involvement, appeared to be responsible for disease severity.
Pediatric acute respiratory distress syndrome (PARDS) is one of the most complex pathologies to manage in pediatric critical care medicine. Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology (PARDIE) study found 3.2% of 23,280 patients were admitted to pediatric intensive care unit (PICU) suffered from PARDS and 6.1% among those required mechanical ventilation.6 The authors also found the mortality rates between 17 and 32%. The primary management of PARDS is based on supportive care, mainly focused on protecting the lungs from any further insults. However, pediatric intensivists face more significant challenges due to the overlap of several underlying diseases, especially malnutrition, chronic lung disease, congenital heart defects, and bronchiolitis. COVID-19 infections and associated ARDS are the new puzzle for the pediatric intensivists especially during the challenging period of pandemic.
In this issue of the Indian Journal of Critical Care Medicine, Sarkar et al. elegantly researched the clinical course of children with COVID-19 associated PARDS along with the predictors of severity.7 The authors must be admired for throwing light on this topic despite the hard time for the healthcare professionals. The understanding of COVID-19 associated with PARDS has a real practical benefit, especially in resource-limited settings where any disease outbreaks or pandemics pose immense challenges in managing sick patients. In this retrospective study, Sarkar et al. studied 128 pediatric COVID-19 patients requiring PICU care. Among the PICU-admitted cases, 18 (14%) developed ARDS, 6 (33.3%) had severe ARDS, and 3 (16.6%) succumbed to death. This study showed some minor deviation from other published literature, where 5–8% of pediatric COVID patients developed ARDS.8,9
Identification of the predictive factors of severe ARDS and the risk factors of mortality was another vital aspect of the study by Sarkar et al.7 In line to index study underlying comorbid conditions, like obesity, chronic neurodevelopment disorders, asthma, malnutrition overcrowding are some other risk factors associated with severe ARDS were found in different pediatric population.10,11 Though the study was retrospective chart review done in a single-center, it may show the pathway to the future management of pediatric COVID-19 patients especially in the era where the dawn of pandemic is still unclear toward the scientists and clinicians.
Footnotes
Source of support: Nil
Conflict of interest: None
Orcid
Rohit Bhowmick https://orcid.org/0000-0002-2589-4499
Krishna M Gulla https://orcid.org/0000-0001-5031-5754
References
- 1.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Parcha V, Booker KS, Kalra R, Kuranz S, Berra L, Arora G, et al. A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States. Sci Rep. 2021;11(1):10231. doi: 10.1038/s41598-021-89553-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Swann OV, Holden KA, Turtle L, Pollock L, Fairfield CJ, Drake TM, et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. British Medical Journal. 2020;370:m3249. doi: 10.1136/bmj.m3249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614–14621. doi: 10.1128/JVI.79.23.14614-14621.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Saule P, Trauet J, Dutriez V, Lekeux V, Dessaint J-P, Labalette M. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev. 2006;127(3):274–281. doi: 10.1016/j.mad.2005.11.001. [DOI] [PubMed] [Google Scholar]
- 6.Khemani RG, Smith L, Lopez-Fernandez YM, Kwok J, Morzov R, Klein MJ, et al. Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. Lancet Respir Med. 2019;7(2):115–128. doi: 10.1016/S2213-2600(18)30344-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sarkar M, Das B, Mahapatra MK, Roychowdhoury S, Das S, Konar MC. A Retrospective Analysis of Clinical Manifestations, Management and Outcome of Acute Respiratory Distress Syndrome Associated with Coronavirus Disease-2019 Infection in Children. Indian J Crit Care Med. 2022;26(3):331–338. doi: 10.5005/jp-journals-10071-24145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Garazzino S, Montagnani C, Donà D, Meini A, Felici E, Vergine G, et al. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020. Euro Surveill. 2020;25(18) doi: 10.2807/1560-7917.ES.2020.25.18.2000600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653–661. doi: 10.1016/S2352-4642(20)30177-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. 2021;4(6):e2111182. doi: 10.1001/jamanetworkopen.2021.11182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sanchez-Piedra C, Gamiño-Arroyo A-E, Cruz-Cruz C, Prado-Galbarro F-J. Impact of environmental and individual factors on COVID-19 mortality in children and adolescents in Mexico: an observational study. Lancet Reg Health Am. 2022;8:100184. doi: 10.1016/j.lana.2022.100184. [DOI] [PMC free article] [PubMed] [Google Scholar]